LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.

Thierry PoynardValentina PetaOlivier DeckmynMona MunteanuJoseph MoussalliYen NgoMarika RudlerPascal LebrayRaluca PaisLuminita BonyhayFrederic CharlotteVincent ThibaultLaetitia FartouxOlivier LucidarmeDaniel EyraudOlivier ScattonEric SavierMarc Antoine ValantinAn NgoFabienne DraneOlivier RosmorducFrançoise Imbert-BismutChantal HoussetDominique ThabutVlad Ratziunull null

Published in: Alimentary pharmacology & therapeutics (2018)

In patients with chronic liver disease the LCR1 and LCR2 tests identify those with a high risk of liver cancer, including in those without cirrhosis. NCT01927133.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
patient reported outcomes